Market Research Logo

Global Tuberculosis Drug Market 2017-2021

Global Tuberculosis Drug Market 2017-2021

About Tuberculosis Drug

Tuberculosis (TB) is caused by Mycobacterium tuberculosis and often affects the lungs. It spreads from person to person through the air in the form of a cough, sneeze or spit. TB affects adults more when compared with children.

Technavio’s analysts forecast the global tuberculosis drug market to grow at a CAGR of 3.17% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global tuberculosis drug market for 2017-2021. To calculate the market size, the report considers the volume and services.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Tuberculosis Drug Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key vendors
  • Lupin
  • Otsuka Novel Products
  • Pfizer
  • Sandoz
  • Sanofi
Other prominent vendors
  • AstraZeneca
  • Archivel Farma
  • bioMérieux
  • Cepheid
  • EIKEN CHEMICAL
  • Epistem
Market driver
  • Increase in outbreak of TB-HIV co-infections
  • For a full, detailed list, view our report
Market challenge
  • Insufficient demand and high drug cost in developed countries
  • For a full, detailed list, view our report
Market trend
  • Focus on development of shorter TB drug regimens
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Key market highlights
  • Key pipeline
    • Table Pipeline analysis
    • Table Key clinical trials
  • Market landscape
    • Market overview
      • Table Global TB drugs market snapshot
    • Market size and forecast
      • Table Global TB drugs market 2016-2021 ($ millions)
      • Table Opportunity analysis in global TB drugs market
    • Five forces analysis
      • Table Five forces analysis
  • High burden countries (HBCs)
    • Categorization of HBCs
      • Table List of major HBCs
  • TB diagnostics
    • Overview
      • Table Advanced technologies used for TB diagnostics
  • Market segmentation by disease type
    • Global latent TB market
    • Global active TB market
      • Table Tests recommended for diagnosis of active TB
  • Market segmentation by drug class
    • Global first-line anti-TB drugs market
      • Table Drugs used as first-line anti-TB agents
      • Table Global first-line anti-TB drugs market 2016-2021 ($ millions)
    • Global second-line anti-TB drugs market
      • Table Drugs used as second-line anti-TB agents
      • Table Global second-line anti-TB drugs market 2016-2021 ($ millions)
  • Geographical segmentation
    • TB drugs market in Americas
      • Table TB drugs market scenario in Americas
      • Table TB drugs market in Americas 2016-2021 ($ millions)
      • Table Number of TB cases reported in US 2010-2015
    • TB drugs market in EMEA
      • Table TB drugs market scenario in EMEA
      • Table TB drugs market in EMEA 2016-2021 ($ millions)
    • TB drug market in APAC
      • Table TB drugs market scenario in APAC
      • Table TB drugs market in APAC 2016-2021 ($ millions)
  • Market drivers
    • Increase in outbreak of TB-HIV co-infections
    • Emergence of MDR-TB and XDR-TB strains
    • Increasing incidence of TB in Africa and Asia
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Insufficient demand and high drug cost in developed countries
    • Liberal regulations and lack of awareness in developing countries
    • Limited diagnostic procedures
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Increased spending on TB diagnostic kits
    • Focus on development of shorter TB drug regimens
    • Increased focus on TB vaccine development
      • Table Testing process in BCG vaccines
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global TB drug market 2016
    • Key news
  • Key vendor analysis
    • Lupin
      • Table Lupin: Key highlights
      • Table Lupin: Strength assessment
      • Table Lupin: Strategy assessment
      • Table Lupin: Opportunity assessment
    • Otsuka Novel Products
      • Table Otsuka Novel Products: Key highlights
      • Table Otsuka Novel Products: Strength assessment
      • Table Otsuka Novel Products: Strategy assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Sandoz
      • Table Sandoz: Key highlights
      • Table Sandoz: Strength assessment
      • Table Sandoz: Strategy assessment
      • Table Sandoz: Opportunity assessment
    • Sanofi
      • Table Sanofi: Key highlights
      • Table Sanofi: Strength assessment
      • Table Sanofi: Strategy assessment
      • Table Sanofi: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report